SIDT1 | SID1 transmembrane family, member 1 | Predicted membrane proteins Transporters
| | | | | Mixed |
SIDT2 | SID1 transmembrane family, member 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC10A5 | Solute carrier family 10, member 5 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC11A2 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A2 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A4 | Solute carrier family 12 (potassium/chloride transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A6 | Solute carrier family 12 (potassium/chloride transporter), member 6 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A7 | Solute carrier family 12 (potassium/chloride transporter), member 7 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC12A9 | Solute carrier family 12, member 9 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC13A1 | Solute carrier family 13 (sodium/sulfate symporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A4 | Solute carrier family 13 (sodium/sulfate symporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC14A2 | Solute carrier family 14 (urea transporter), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC15A2 | Solute carrier family 15 (oligopeptide transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC15A3 | Solute carrier family 15 (oligopeptide transporter), member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC15A4 | Solute carrier family 15 (oligopeptide transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC15A5 | Solute carrier family 15, member 5 | Predicted membrane proteins Transporters
| | | | | Not detected |
SLC16A1 | Solute carrier family 16 (monocarboxylate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A10 | Solute carrier family 16 (aromatic amino acid transporter), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A11 | Solute carrier family 16, member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A12 | Solute carrier family 16, member 12 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC16A13 | Solute carrier family 16, member 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A14 | Solute carrier family 16, member 14 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC16A2 | Solute carrier family 16, member 2 (thyroid hormone transporter) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A4 | Solute carrier family 16, member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC16A5 | Solute carrier family 16 (monocarboxylate transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC16A6 | Solute carrier family 16, member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A7 | Solute carrier family 16 (monocarboxylate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC16A8 | Solute carrier family 16 (monocarboxylate transporter), member 8 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A9 | Solute carrier family 16, member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC17A5 | Solute carrier family 17 (acidic sugar transporter), member 5 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A7 | Solute carrier family 17 (vesicular glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A8 | Solute carrier family 17 (vesicular glutamate transporter), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A9 | Solute carrier family 17 (vesicular nucleotide transporter), member 9 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC18A1 | Solute carrier family 18 (vesicular monoamine transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC18A2 | Solute carrier family 18 (vesicular monoamine transporter), member 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |